Study: Mevacor may fight cancer

The cholesterol-lowering drug Mevacor may help people who suffer from cancer achieve remission, researchers say. Early studies showed that Mevacor killed or impaired cancer cells in lab tests, but it required doses too high for humans to tolerate in order to be used as a cancer treatment. Now researchers say that when cancer patients are given a precisely timed regimen of low-dose interferon with Mevacor, their tumors shrink, sometimes within just a few weeks. Mevacor has been tested on patients with melanoma, but researchers say it may also help other cancers, including pancreatic cancer, colon cancer, and kidney cancer.  Read full story >